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Abstract
There has been a renewed debate over whether AIDS deserves an exceptional response. We argue
that as AIDS is having differentiated impacts depending on the scale of the epidemic, and population
groups impacted, and so responses must be tailored accordingly. AIDS is exceptional, but not
everywhere. Exceptionalism developed as a Western reaction to a once poorly understood
epidemic, but remains relevant in the current multi-dimensional global response. The attack on
AIDS exceptionalism has arisen because of the amount of funding targeted to the disease and the
belief that AIDS activists prioritize it above other health issues. The strongest detractors of
exceptionalism claim that the AIDS response has undermined health systems in developing
countries.
We agree that in countries with low prevalence, AIDS should be normalised and treated as a public
health issue--but responses must forcefully address human rights and tackle the stigma and
discrimination faced by marginalized groups. Similarly, AIDS should be normalized in countries with
mid-level prevalence, except when life-long treatment is dependent on outside resources--as is the
case with most African countries--because treatment dependency creates unique sustainability
challenges. AIDS always requires an exceptional response in countries with high prevalence (over
10 percent). In these settings there is substantial morbidity, filling hospitals and increasing care
burdens; and increased mortality, which most visibly reduces life expectancy. The idea that
exceptionalism is somehow wrong is an oversimplification. The AIDS response can not be mounted
in isolation; it is part of the development agenda. It must be based on human rights principles, and
it must aim to improve health and well-being of societies as a whole.
Introduction
Countries are struggling to deliver on their pledges for
universal access to a comprehensive set of interventions
for HIV prevention, treatment, care and support, while the
global economy is in crisis. At the same time there has
been a renewed debate over whether AIDS deserves an
exceptional response. This dispute has divided scientists,
civil society, researchers and policy-makers. While delib-
eration is important, we must maintain focus on the 7000
people who are newly infected with HIV every day, and on
those who continue to die from a treatable and preventa-
ble disease.
The many AIDS epidemics affect countries and specific
groups in various ways and to differing degrees. In Swazi-
land, 26 percent of the adult population is infected, in
Kenya 7.1 percent is infected, while in Canada, only 0.4
percent is infected. South Africa, has the highest number
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of people living with HIV and AIDS in the world - an esti-
mated at 5.7 million men, women and children [1]. AIDS
remains the leading cause of death in Africa.
In wealthy countries, localized epidemics occur in specific
contexts. On Vancouver's Downtown Eastside, the infec-
tion rate amongst commercial sex workers is 26 percent
[2]. In Estonia, 72 percent of injecting drug users (IDU)
are HIV positive and, while the national rate among IDU
in Russia is 14 percent, it is 74 percent in the city of Biysk
[3]. In the Ukraine, which is experiencing an already trou-
bling population decline, the World Bank projects that
AIDS will cause an additional 300,000-500,000 deaths by
2014 [4]. The HIV prevalence among men who have sex
with men in Bangkok and Yangon is estimated at 30 per-
cent [5,6]. AIDS is having differentiated impacts depend-
ing on place and population group, and responses must
be tailored accordingly. We argue that AIDS is excep-
tional, but not everywhere. Exceptionalism is defined as
the need to recognize that AIDS, in some contexts,
presents unique impacts and challenges, and requires a
response that is innovative, well resourced and of unprec-
edented commitment.
The debate
In the early 1980s, AIDS was a new disease from an
unknown retrovirus; its mode of transmission was myste-
rious, initially affecting mostly the gay population in the
West. Its exceptional status was promoted through an
alignment of interests of the medical community and gay
advocates [7]. There was a real concern that the disease
would spread across the populations, which lead to
national campaigns with leaflets going to every household
in a number of OECD countries (in Britain, remarkably,
this campaign 'Don't die of ignorance' took place under a
conservative government). When the feared generalised
epidemic did not occur in the West, and with treatment
becoming available from the mid 1990s, intellectuals
called for an end to AIDS exceptionalism [8].
Internationally, AIDS became increasingly 'globalised.' In
2000, the United States National Intelligence Council
(NIC) produced the 'The Global Infectious Disease Threat
and Its Implications for the United States' [9]. Six months
later, the UN Security Council passed Resolution 1308,
stating: "the HIV/AIDS pandemic, if unchecked, may pose
a risk to stability and security" [10]. At the 13th Interna-
tional AIDS Conference, in Durban in 2000, the inequity
of treatment was highlighted. AIDS had become a chronic
disease in the West, and a death sentence elsewhere. Activ-
ists demanded that the drugs, which were beyond the
reach of most people in the developing world, should be
made universally available.
Manufacture and sale of generic drugs, plummeting prices
and growing international initiatives, resulted in an aston-
ishing treatment roll-out, making the response once again
exceptional. The costs of ART fell from about $10,000 per
patient per year to $350 in the early 2000s [11]. In 2002,
the Global Fund for AIDS, TB and Malaria was estab-
lished. In 2003, President Bush pledged $15 billion
toward his Presidential Emergency Programme for AIDS
Relief (PEPFAR) and the World Health Organization
launched the '3 × 5' campaign to get 3 million people on
treatment by 2005. Annual funding rose from US $300
million in 1996, to $13.7 billion in 2008 [12].
In our view, AIDS exceptionalism is under attack from two
sources. The first were characterized by Stephen Lewis,
speaking at the International AIDS Society Conference on
Pathogenesis, Treatment and Prevention in Cape Town in
July 2009, as: "the pinched bureaucrats and publicity-
seeking academics who advocate exchanging the health of
some for the health of others - who propose robbing Peter
to pay Paul rather than arguing, in principled fashion, that
money must be found for every imperative, including
maternal and child health, and sexual and reproductive
health, and environmental health as well as all the
resources required to turn the tide of the AIDS pandemic"
[13]. The second group is public health specialists and
academics who wish to enter a serious policy debate about
health priorities and resources and how they are and
should be allocated. They are concerned by what appears
in some contexts as disproportionate amounts of funding
targeted at AIDS and because of the belief that AIDS activ-
ists prioritize it above other health problems. This is a
valid dialogue and needs to be entered with honesty and,
above all, data.
A series of books and articles set out the exceptionalism
debate. Chin argued UNAIDS and AIDS activists perpetu-
ate certain myths about the epidemiology of HIV so as to
keep the disease on the political agenda and, by implica-
tion, ensure funding and jobs [14]. Pisani wrote that the
flow of funds to AIDS "rubs out common sense," and that
scientists have allowed themselves to be compromised by
the money and politics of the disease [15]. Epstein sug-
gested that the main driver of the epidemic in Africa is
concurrent sexual partnering, but that there has been
silence on this issue because people, especially male deci-
sion-makers, are not prepared to address their own behav-
iours (or aspirations) [16]. All three allege that the
epidemic has been exagerated and money and resources
allocated to inappropriate responses.
The strongest (and most polemical) arguments were
advanced by England, who claimed that AIDS financing
has undermined health systems in developing countries
[17,18]. He accuses UNAIDS of creating a vertical pro-Globalization and Health 2009, 5:15 http://www.globalizationandhealth.com/content/5/1/15
Page 3 of 6
(page number not for citation purposes)
gram that diverts human and other resources away from
general public health priorities and leads to inefficiencies
in the public sector. He draws attention to the tendency
among some donors to provide large volumes of off-
budget funding dedicated to AIDS-specific programs,
"which provides no incentives for countries to create sus-
tainable systems, entrenches bad planning and budgeting
practices, undermines sensible reforms such as sector-
wide approaches and basket funding ... achieves poor
value for money, and increases dependency on aid" [19].
The realization that AIDS programs have sometimes, in
their single-minded zeal for results in less than optimum
contexts, been misinformed and poorly planned should
be taken as constructive criticism, instead of eliciting
defensive responses. We know funding has not always
been applied where it is most required. For example, in
West Africa sex trade workers are a core transmitter group,
but most prevention funding is applied to the general
population. The Commission on AIDS in Asia found that
almost 90 percent of all investment in prevention went to
areas with insufficient returns [20]. Planning and funding
for AIDS programmes must be improved, especially since
resources are tight.
There is also the issue of what Peter Piot, former UNAIDS
Executive Director, describes as "The health system's
myth. The myth that if we just, if we only strengthen
health systems this will solve everything, including AIDS"
[21]. The impact of AIDS specific initiatives on health sys-
tems has been subject of limited empirical research but
much debate. Yu, et al. review both sides and conclude
that, while there is imperfect data that suggest AIDS pro-
grammes occasionally divert resources, the overwhelming
evidence indicates that these programmes improve pri-
mary care and health outcomes by drawing attention and
resources to otherwise ignored regions and populations
[22]. Rather than disbanding AIDS programs, the authors
argue: "Current scaled-up responses to HIV/AIDS must be
maintained and strengthened. Instead of endless debate
about the comparative advantages of vertical and horizon-
tal approaches, partners should focus on the best ways for
investments in response to HIV to also broadly strengthen
the primary health care systems." These conclusions are
supported by the analysis of the WHO Maximizing Posi-
tive Synergies Collaborative Group [23]. Michel Sidibé,
Executive Director of UNAIDS, is applying such findings
by maximizing positive externalities of AIDS responses
further by seeking opportunities to ensure that they are
leveraged to support the Millenuim Development Goals
(MDGs), human rights and development agendas more
generally- [24] a neccessary response if the universal
access targets are to be met in 2010, and the MDGs in
2015.
Concentrated epidemics: normalize and focus 
on rights, stigma and discrimination
In October 2008, the Lancet wrote "A view beyond HIV/
AIDS will reinforce plurality and justice, protecting
minorities and thus wider majorities" [25]. In countries
with low prevalence (taken to be generally below three
percent), AIDS should be normalised. By normalized we
mean that AIDS is viewed and addressed as one of many
important health issues that are integrated into public
health systems; the disease itself may not be given priority,
though the needs of those most at risk and affected may
be prioritized. A diverse group of countries fall into this
catagory--for example Senegal, India, the Russian Federa-
tion, Thailand and Brazil. In these countries the epidemic
is concentrated in what are often known as most-at-risk-
populations--usually men who have sex with men, inject-
ing drug users and sex workers and their clients. These
groups are often stigmatized, marginalized and criminal-
ized, which inhibits the effectiveness of prevention pro-
grams and restricts access to public health services.
Normalizing the AIDS response in these contexts includes
the creation of supportive legal and social environments
that enable the provision and uptake of services so every-
one benefits from the same rights, treatment and services.
Extra measures may need to be taken to ensure that mar-
ginalized groups have equal access. It may be that such
groups are not seen as meriting special treatment and
therefore the role of pressure groups is important.
Addressing AIDS as a 'normal' public health issue
counters the stigma that is directed towards at risk groups
by labeling them as 'different;' instead of getting 'special
treatment' they get the treatment they deserve. This could
offset the tendency of some governments to shirk respon-
sibility for providing for these groups by labeling them as
'special interest groups' or those who make specific 'life
style choices.'
A 'normal' public health response is also necessarily
adaptable; most at risk population groups are not static.
For example, in Russia, young male injection drug users
were recognized as the most at risk group until recently.
However, the proportion of infections amongst women
rose from 13.0 percent in 1995 to 44.0 percent in 2006
[26], indicating a developing need for interventions that
address women's sexual and reproductive rights, and pre-
vention of vertical transmission. Similarly, the distinction
of normalized and exceptional is not static but fluid. For
example, in Eastern Europe AIDS could be argued to
require an exceptional response as it is contributing to a
troubling population decline. In such situations, a public
health approach can provide monitoring of infection rates
and impacts, and raise the alarm if and when responses
need to adapt or scale-up.Globalization and Health 2009, 5:15 http://www.globalizationandhealth.com/content/5/1/15
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Mid-level prevalence: exceptional responses if 
aid dependent
Similarly, AIDS should be normalized in countries with
mid-level prevalence, except when life-long treatment is
dependent on outside resources - as is the case with most
African countries - because treatment dependency creates
unique sustainability challenges. Once treatment begins,
medications must be taken for life. The drugs are expen-
sive and patients will, after a period of time, need to move
from first-line (costing about $92 per patient per year) to
second-line treatment (at about $1214 per patient per
year) [27]. The required expenditure per AIDS patient in
sub-Sahara Africa often exceeds per capita health expend-
iture. For example, in Malawi one programme reported
the annual recurrent costs for direct care per patient on
ART were $237, [28] while the national health expendi-
ture per capita was $132 per person per year and the gov-
ernment's expenditure was just $14 [29]. Across the
border, Mozambique's per capita health expenditure is $9
while Zambia's is $36. These, and countries like them can-
not provide treatment without extensive assistance, which
will have to be long term and predicable [30]. The poorer
the country and the greater the disease burden, the more
dependent it will be on international aid to provide treat-
ment and care. Over has argued that this situation creates
an 'international entitlement' as foreign nationals become
'entitled' to access to treatment and care financed through
aid, and asks if this is sustainable [31].
Between 2005 and 2008, 60 percent of funding for AIDS
responses in sub-Sahara Africa came from multilateral,
bilateral and philanthropic organizations, and more than
half of AIDS funding came from the United States [32]. In
Mozambique, 98 percent of funding for HIV and AIDS
programmes was provided by international donors, and
78 percent of that from PEPFAR. As Garrett and Schneider
write, "Few HIV/AIDS initiatives were designed with the
thought of an exit strategy in mind... All too often donor's
best intentions to fight HIV/AIDS have increased depend-
ency" [33]. While this situation is troubling, the alterna-
tive--interrupting treatment and rupturing the implicit
north-south compact of global solidarity--would be even
more so. If anything, this extraordinary situation of donor
dependency demands new and creative responses that
particularly focus on strengthening local public health
capacity to provide treatment and care and massively scal-
ing up more effective prevention interventions.
Planning for HIV and AIDS funding also demands
urgency: the current economic crisis, which has hit the
United States particularly hard, threatens the sustainabil-
ity of AIDS funding. It is unlikely the required US $25.1
billion for low- and middle-income countries for treat-
ment and prevention programs in 2010 will be forthcom-
ing [34]. The challenge to the international community is
now to develop sustainable and innovative financing ini-
tiatives to reduce vulnerabilities to fluctuations in interna-
tional aid.
High prevalence regions require an exceptional 
response
Even where treatment is available, AIDS requires an excep-
tional response in countries with high prevalence (over 10
percent) due to the need to provide treatment or face
increased morbidity and mortality, and the continued
challenges of implementing effective prevention pro-
grams. High incidence of AIDS related illness and death
has demographic and social impacts that will be felt for
generations. Life expectancy declines, the size and the
structure of the populations changes, and numbers of
orphans increase. For example, in Botswana life expect-
ancy fell from 56 years during the period 1970 to 1975; to
46.6 years in 2000 to 2005 [35]. In South Africa, the total
annual deaths increased by 87 percent from 1997 to 2005,
with at least 40 percent estimated to have been AIDS-
related. HIV is unique as it spreads predominantly
between reproductive age adults, leaving the elderly and
young to care for themselves. The number of orphans due
to AIDS in sub-Sahara Africa increased from 6,500,000 in
2001, to 11,600,000 in 2007.
In high prevalence countries the epidemic has a particu-
larly unique and troubling characteristic, often referred to
as 'the feminisation of AIDS' [36]. In South Africa, women
between the ages of 15 and 24 account for 90 percent of
new HIV infections. Women are both biologically and
socially more vulnerable to HIV; this is often related to
women's lack of sexual and reproductive rights. According
to the Medical Research Council of Cape Town University,
one in four women in South Africa report abuse by an inti-
mate partner [37]. A study from India finds that women
who experience intimate partner violence consistently
demonstrate greater HIV prevalence [38]. Therefore, Lewis
rightly argues, "Bringing an end to sexual violence is a
vital component in bringing an end to AIDS" [39].
Though there has been rhetorical commitment to promot-
ing women's rights, we have yet to see outcomes in terms
of substantial decreases in levels of gender-based violence
and increased sexual and reproductive rights. Too many
programs continue to ignore the reality of gender inequal-
ity. For example, the popular ABC (abstain, be faithful,
use condoms) prevention campaign ignores the reality
that wives may not be able to abstain or use condoms
without their husband's 'permission.' It does not recog-
nize that in many countries a man cannot be accused, in
law, of raping his wife. In Kenya, this contributes to high
prevalence rates amongst women aged 15 to 49, which are
nearly twice those of men [40]. Addressing the feminiza-
tion of AIDS requires unprecedented political commit-
ment to and resources for initiatives that promote genderGlobalization and Health 2009, 5:15 http://www.globalizationandhealth.com/content/5/1/15
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equality. This includes programs that empower men to
make choices that are best for their families and commu-
nities.
In the context of high levels illness and mortality, the HIV
and AIDS response also must recognize the increased care
burden placed on women. UNAIDS estimates that 90 per-
cent of HIV and AIDS related caregiving in sub-Sahara
Africa is done in the home [41], and the majority of this
caregiving is done by women. Research on HIV and AIDS
care at the household level suggests it is having dispropor-
tionate negative effects on women; it reduces economic
and educational opportunities at the same time as increas-
ing household costs, causes emotional strain and poor
mental health, and adversely affects women's own physi-
cal health [42]. Increased support for caregivers, both
financially and politically, can both ensure effective care
and treatment programs, and contribute to women's
empowerment. A key component of such responses has to
be linking caregivers with public health systems and other
support structures, while building partnerships and pro-
moting gender equality [43]. This response has to be inte-
grated, and has to be rights-based.
In high prevalence contexts AIDS must be mainstreamed
across a nation. For example, in education there will be
issues of teacher deaths, children living with HIV and the
need to prevention programmes; in agriculture HIV/AIDS
may be implicated in lower production [44]. The health
sector faces obvious challenges in providing treatment,
but frequently ignore the human resource implications of
infection among their own staff. Above all politicians and
senior civil servants need to recognize that they are faced
by a long wave event
We have argued that AIDS is exceptional but that that
response should not be mounted in isolation. The Maxi-
mizing Positive Synergies report identifies a range of
opportunities for building on the results-based pro-
grammes established to address HIV and AIDS to
strengthen health sectors and systems [45]. For example,
the rapid scaling up of interventions to prevent mother-
to-child transmission of HIV provide an ideal platform to
offer other maternal and child health, as well as sexual
and reproductive heath and rights services. HIV service
sites can be used for intensified TB case finding, TB ther-
apy and TB infection control. Supply chains developed to
deliver AIDS drugs and diagnostics should benefit all
drugs and diagnostics--and the same applies to trained
staff and surveillance and information systems. Given that
more people are infected than put on drugs, and the spi-
raling costs of treatment, the focus on prevention must
not be lost. Prevention and treatment must be imple-
mented hand-in-hand.
Conclusion
The idea that exceptionalism is somehow wrong is an
oversimplification. While normalizing the response
where AIDS is located largely in specific population
groups can ensure equitable services and treatment by
addressing stigma and discrimination. AIDS must be seen
as exceptional in those places where it is having long term
development impacts due to high incidences of illness
and death. Critics of AIDS exceptionalism do not take into
account the unique situation where international aid is lit-
erally keeping people alive. In high prevalence countries,
prevention programs have yet to slow the rate of infection,
and finding ways to do so will require creativity and an
unprecedented political commitment. The AIDS response
can not be mounted in isolation; it is part of the develop-
ment agenda. It must be based on human rights princi-
ples, and it must aim to improve health and well-being of
societies as a whole.
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